Applied Therapeutics, Inc. (APLT)

Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	79.4	49.9	16.66	53.89	57.47
Short-Term Investments	-	-	13.92	26.94	39.36
Cash & Short-Term Investments	79.4	49.9	30.58	80.82	96.83
Cash Growth	59.12%	63.17%	-62.16%	-16.53%	149.21%
Other Receivables	-	-	0.28	0.53	0.51
Receivables	-	-	0.28	0.53	0.51
Prepaid Expenses	1.74	1.35	2.12	2.56	2.91
Other Current Assets	2.51	3.13	4.33	4.48	2.35
Total Current Assets	83.65	54.39	37.31	88.39	102.59
Property, Plant & Equipment	2.79	0.45	0.86	1.3	1.71
Other Long-Term Assets	0.25	-	0.2	0.2	0.2
Total Assets	86.69	54.83	38.36	89.89	104.51
Accounts Payable	4.43	1.74	4.53	9.46	0.64
Accrued Expenses	15.33	13.93	13.65	14.78	18.56
Short-Term Debt	-	0.31	0.62	0.79	1.07
Current Portion of Leases	0.41	0.43	0.48	0.44	0.41
Current Unearned Revenue	0.21	0.67	-	-	-
Other Current Liabilities	6.92	54.1	14.14	0.99	0.55
Total Current Liabilities	27.3	71.18	33.42	26.46	21.24
Long-Term Leases	2.39	0.04	0.41	0.89	1.33
Other Long-Term Liabilities	-	0.76	0.46	-	-
Total Liabilities	29.69	71.98	34.3	27.35	22.57
Common Stock	0.04	0.01	0.01	0	0
Additional Paid-In Capital	631.18	451.43	352.83	328.96	242.78
Retained Earnings	-574.21	-468.59	-348.82	-266.32	-160.73
Comprehensive Income & Other	-	-	0.05	-0.11	-0.11
Total Common Equity	57.01	-17.15	4.06	62.54	81.94
Shareholders' Equity	57.01	-17.15	4.06	62.54	81.94
Total Liabilities & Equity	86.69	54.83	38.36	89.89	104.51
Total Debt	2.8	0.78	1.51	2.12	2.81
Net Cash (Debt)	76.6	49.12	29.07	78.7	94.02
Net Cash Growth	55.95%	68.99%	-63.07%	-16.29%	155.38%
Net Cash Per Share	0.55	0.58	0.77	3.07	4.28
Filing Date Shares Outstanding	141.58	105.89	48.11	26.22	26.01
Total Common Shares Outstanding	137.23	84.87	48.06	26.22	22.49
Working Capital	56.35	-16.8	3.88	61.93	81.36
Book Value Per Share	0.42	-0.20	0.08	2.39	3.64
Tangible Book Value	57.01	-17.15	4.06	62.54	81.94
Tangible Book Value Per Share	0.42	-0.20	0.08	2.39	3.64

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q